Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
26.36 USD | -4.25% | -21.48% | -60.79% |
Apr. 30 | Medifast Shares Drop as Q1 Adjusted Earnings, Revenue Decline; Sets Q2 Guidance | MT |
Apr. 30 | Wall Street Poised for Cautious Day Ahead of Key Numbers, Earnings, Fed Report | MT |
Financials (USD)
Sales 2024 * | 646M | Sales 2025 * | 663M | Capitalization | 294M |
---|---|---|---|---|---|
Net income 2024 * | 9M | Net income 2025 * | 20M | EV / Sales 2024 * | 0.18 x |
Net cash position 2024 * | 178M | Net cash position 2025 * | 218M | EV / Sales 2025 * | 0.12 x |
P/E ratio 2024 * |
31.6
x | P/E ratio 2025 * |
14.6
x | Employees | 634 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.93% |
Latest transcript on Medifast, Inc.
1 day | -22.47% | ||
1 week | -17.62% | ||
1 month | -28.16% | ||
3 months | -49.62% | ||
6 months | -60.19% | ||
Current year | -59.04% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel Chard
CEO | Chief Executive Officer | 59 | 16-10-02 |
James Maloney
DFI | Director of Finance/CFO | 56 | 20-07-19 |
Anthony Tyree
COO | Chief Operating Officer | 58 | 18-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Chard
CEO | Chief Executive Officer | 59 | 16-10-02 |
Jeffrey Brown
BRD | Director/Board Member | 63 | 15-06-16 |
Andrea B. Thomas
BRD | Director/Board Member | 59 | 19-06-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.42% | 27 M€ | -6.44% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 26.36 | -4.25% | 934 833 |
24-04-30 | 27.53 | -22.47% | 1,871,293 |
24-04-29 | 35.51 | +5.34% | 686,706 |
24-04-26 | 33.71 | +0.63% | 332,426 |
24-04-25 | 33.5 | -0.21% | 323,644 |
Delayed Quote Nyse, April 30, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-59.04% | 294M | |
+13.21% | 8.15B | |
-0.47% | 7.23B | |
+12.30% | 6.65B | |
-6.99% | 3.72B | |
-7.95% | 3.64B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-43.32% | 863M | |
-22.54% | 799M |
- Stock Market
- Equities
- MED Stock